Top compounds associated with response to DTNA


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 7e-11
mRNA UNC0638 GDSC1000 pan-cancer AAC 0.18 4e-09
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 7e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 9e-09
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 1e-08
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.18 6e-08
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.16 4e-07
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.17 6e-07
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.17 7e-07
Download CSV